1.
Presse Med
; 23(2): 99, 1994 Jan 22.
Artigo
em Francês
| MEDLINE
| ID: mdl-8140085
2.
Nouv Presse Med
; 11(22): 1738-40, 1982 May 13.
Artigo
em Francês
| MEDLINE
| ID: mdl-6124947
RESUMO
The action of bromazepam was assessed in 30 patients whose dominant symptom was anxiety in clinical presentations of neurosis, depression, drug-addiction or alcoholism, senile dementia or oligophrenia. The doses administered ranged from 6 to 12 mg/day and in some cases from 18 to 36 mg/day. Distinct improvement was noted in 20 patients, the effects of the drug on anxiety being manifested within 2 to 3 days. The somatic symptoms of anxiety and sleep disturbances were also improved. However, depressive and psychotic symptoms remained unchanged and it was necessary to combine diazepam with other drugs. Side-effects consisted of daytime somnolence in 2 cases and feeling of dizziness in 3 cases.